Why is Astrazeneca Phar falling/rising?

As of 23-Sep, Astrazeneca Pharma India Ltd's stock price is currently at 8,750.50, reflecting a decrease of 106.75 or 1.21%. The stock has been underperforming, having fallen for the last four consecutive days, resulting in a total decline of 3.89% during this period. Despite this recent downturn, the company has shown strong performance over the longer term, with a 29.66% increase in the past year and a remarkable 175.18% rise over the last three years. The stock's performance today has also been below sector expectations, underperforming by 0.86%. Additionally, investor participation has decreased, with delivery volume dropping by 31.9% compared to the five-day average, indicating a potential lack of confidence among investors.
In the broader market context, the stock's short-term decline of 3.05% over the past week contrasts with the Sensex, which has only decreased by 0.34%. This suggests that Astrazeneca Pharma is facing specific challenges that are not affecting the broader market to the same extent. However, the company maintains a high management efficiency with a return on equity of 20.34% and a low debt-to-equity ratio, which are positive indicators. Furthermore, the company has reported positive results for the last three consecutive quarters, with significant growth in profit after tax and net sales. Despite the recent price drop, the stock's consistent returns over the years and strong fundamentals suggest that it remains a hold for investors.